Doxycycline in Treating Patients With Chronic Rhinosinusitis With Nasal Polyps
Summary
The Department of Otolaryngology at Mount Sinai is looking for adults with sinus disease with polyps, otherwise called chronic rhinosinusitis with nasal polyps (CRSwNP). Patients may be eligible to enroll in a study offering a cutting-edge therapy to help reduce symptoms and avoid surgery. The treatment combines an antibiotic (doxycycline) with oral steroids. Oral steroids are the mainstay of medical management for patients with CRSwNP. However, recent studies have shown that doxycycline helps improve symptoms as well by reducing inflammation and killing common bacteria that can cause symptoms. This study is the first to evaluate this combination regimen.
Timeline
- Start
- 2014-09
- Primary completion
- 2016-08
- Completion
- 2016-08
Outcome
Outcome not reported
Stopped: “A high percentage of patients were dropping out of the study and were not able to complete the protocol.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Doxycycline | Small molecule | 100 mg | Oral |
| Background | Fluticasone propionate | Other / unclassified | — | Intranasal |
| Background | Methylprednisolone | Other / unclassified | 8 mg | Oral |